Aspira Women’s Health to Announce Year End 2022 Financial Results and Host Conference Call on March 22, 2023

Rhea-AI Summary

Aspira Women’s Health (Nasdaq: AWH) has announced it will release its financial results for the year ended December 31, 2022, on March 22, 2023, after market close. Management will host a conference call at 4:30 PM ET to discuss these results and provide updates on corporate developments. The call can be accessed via toll-free and international numbers, with a dedicated conference ID of 13736207. Aspira is focused on innovative testing options for gynecological health, including Ova1Plus®, aimed at detecting ovarian malignancy risks, and EndoCheck™, a test for endometriosis currently in development.

AUSTIN, Texas, March 03, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today announced that the company will report its financial results for the year ended December 31, 2022 after the market closes on Wednesday, March 22, 2023. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time. Details for the call are below:

Conference Call & Webcast Details
Date:	Wednesday, March 22
Time:	4:30pm ET
Toll Free:	1-877-407-4018
International:	1-201-689-8471
Conference ID:	13736207
Webcast:	Click HERE

About Aspira Women’s Health Inc.
Aspira Women’s Health Inc. is transforming women’s gynecological health with the discovery, development, and commercialization of innovative testing options for women of all races and ethnicities. Ova1Plus^® combines our FDA-cleared products, Ova1^® and OVERA^®, to detect risk of ovarian malignancy in women with adnexal masses planned for surgery. EndoCheck™, Aspira’s first-of-its-kind non-invasive diagnostic test for endometriosis, is currently in development. Visit our website for more information at www.aspirawh.com.

Investor Relations Contact:
Monique Kosse
Managing Director
LifeSci Advisors, LLC
Tel: 212-915-3820

FAQ

When will Aspira Women’s Health report its financial results for 2022?

Aspira Women’s Health will report its financial results for the year ended December 31, 2022, on March 22, 2023.

What time is the Aspira Women’s Health conference call on March 22, 2023?

The conference call will be held at 4:30 PM ET on March 22, 2023.

How can I access the Aspira Women’s Health conference call?

The conference call can be accessed via toll-free number 1-877-407-4018 or international number 1-201-689-8471, using the conference ID 13736207.

What are the products Aspira Women’s Health focuses on?

Aspira Women’s Health focuses on testing options like Ova1Plus® for ovarian malignancy risk detection and is developing EndoCheck™, a non-invasive test for endometriosis.